spacer
home > > media info
MEDIA INFORMATION
spacer
 
 
News and Press Releases

Merck Invests More than 130 Million to Strengthen Manufacturing Capabilities in Molsheim, France

Merck, a leading science and technology company, strengthens its manufacturing capabilities for single-use assemblies, a key technology for the production of Covid-19 vaccines and other lifesaving therapies, by investing more than 130 million in Molsheim, France. The investment is the largest ever in the 50-year history of the site and will create more than 800 jobs by the end of 2028.
More info >>

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement